Vimarsana
Biggest News Aggregation in the World

Page 37 - Clinical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Today - Breaking & Trending Today

Pathomics Health and MAHSA Health sign MOU to launch Joint Centre for Research and Diagnostics for Precision Wellness and Clinical Research - Vimarsana News

Pathomics Health and MAHSA Health sign MOU to launch Joint Centre for Research and Diagnostics for Precision Wellness and Clinical Research

KUALA LUMPUR, MALAYSIA - Media OutReach - 30 December 2022 - Pathomics Health, an organisation with a mission to provide accessible advanced clinical diagnostics, has signed a...

Welcome To IANS Live - NATION - Bharat Biotech's intranasal Covid vaccine priced at Rs 800 - Vimarsana News

Welcome To IANS Live - NATION - Bharat Biotech's intranasal Covid vaccine priced at Rs 800

The vaccine, iNCOVACC (BBV154), is now available on CoWin, and priced at Rs 800 for private markets and Rs 325 for supplies to the Centre and state governments, the Hyderabad-based company said.Last

Soligenix Initiates Phase 2 Clinical Trial of SGX302 (synthetic hypericin) for the Treatment of Mild-to-Moderate Psoriasis - Vimarsana News

Soligenix Initiates Phase 2 Clinical Trial of SGX302 (synthetic hypericin) for the Treatment of Mild-to-Moderate Psoriasis

Study HPN-PSR-01 opens patient enrollment PRINCETON, N.J., Dec. 19, 2022 /PRNewswire/ -- Soligenix, Inc. SNGX (Soligenix or the Company), a late-stage

Driven to prevent cervical cancer worldwide - Vimarsana News

Driven to prevent cervical cancer worldwide

Kathleen Schmeler, M.D., has been working with underserved communities both in the United States and abroad to reduce the incidence of cervical and other women's cancers, such as breast cancer. Now, that passion has helped MD Anderson expand its reach even further, through a new partnership with the World Health Organization (WHO).

Gimv agrees sale of Biolam, three years after buying into French clinical testing lab business - Vimarsana News

Gimv agrees sale of Biolam, three years after buying into French clinical testing lab business

European private equity house Gimv has agreed to sell its stake in clinical testing laboratory business Biolam.